Precision Drug Screening

Efficacy Evaluation in Diverse Backgrounds

Move beyond the limitations of single genetic backgrounds. We evaluate candidates in genetically diverse populations to identify individual response differences early and optimize clinical trial designs.

Start Screening

Population PK/PD

Assess drug metabolism differences across genetic backgrounds to flag potential toxicity risks.

Biomarker Discovery

Identify genetic biomarkers that predict drug response (sensitivity/resistance).

Indication Expansion

Phenotypic screening to discover new efficacies for existing drugs in novel genetic backgrounds.